Mechanism of hepatic drug oxidation and its relationship to individual differences in rates of oxidation in man.
D000284:Administration, Oral; D000328:Adult; D000818:Animals; D000983:Antipyrine / Q000097:blood*; D001706:Biopsy; D003580:Cytochromes / Q000378:metabolism; D006207:Half-Life; D006801:Humans; D007700:Kinetics; D008099:Liver / Q000378:metabolism*; D008297:Male; D008660:Metabolism / Q000187:drug effects; D008862:Microsomes, Liver / Q000201:enzymology / Q000378:metabolism; D008875:Middle Aged; D008954:Models, Biological; D009019:Morphinans / Q000378:metabolism*; D010084:Oxidation-Reduction; D010088:Oxidoreductases; D010653:Phenylbutazone / Q000008:administration & dosage / Q000097:blood* / Q000494:pharmacology; D051381:Rats; D013997:Time Factors
D003580:Cytochromes; D009019:Morphinans; D010088:Oxidoreductases; D010653:Phenylbutazone; D000983:Antipyrine